MeSH tree: D03.383.312.750
British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
Oct 9, 2024
1
0
British pharmaceutical group GSK on Friday welcomed victory in drawn out US litigation regarding its Zantac drug for heartburn that allegedly caused cancer.
Aug 16, 2024
0
0
French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac.
Apr 4, 2024
0
0
Research led by Seng Chan You, MD, at the Yonsei University College of Medicine, Korea, has investigated the risk of cancer associated with use of the drug ranitidine compared to other histamine-2 receptor antagonists (H2RAs) ...
British pharmaceutical group GlaxoSmithKline said Friday it has settled a US lawsuit which had alleged heartburn drug Zantac caused cancer, but admitted no liability.
Jun 23, 2023
0
35
Shares in British pharmaceutical group GlaxoSmithKline and French peer Sanofi jumped Wednesday after a US court dismissed claims that heartburn drug Zantac caused cancer.
Dec 7, 2022
0
5
